Close Menu

The first trial using CRISPR within the human body is to begin this fall to treat a form of blindness, according to the Associated Press.

Editas Medicine and Allergan plan to enroll 18 people with Leber congenital amaurosis, a genetic form of blindness that affects the retina, in their study. According to the AP, Leber congenital amaurosis is the most common cause of inherited childhood blindness.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.